We are live on
!
Find out more
BCWM
Bartlett & Co Wealth Management Portfolio holdings
AUM
$7.99B
1-Year Est. Return
20.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+20.76%
3 Year Est. Return
+62.3%
5 Year Est. Return
+76.31%
10 Year Est. Return
–
AUM
$5.78B
AUM Growth
+$604M
(+12%)
Cap. Flow
+$315M
Cap. Flow
% of AUM
5.44%
Top 10 Holdings %
Top 10 Hldgs %
30.92%
Holding
1,221
New
145
Increased
296
Reduced
158
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$21.8M |
| 2 |
Apple
AAPL
|
+$17.5M |
| 3 |
UnitedHealth
UNH
|
+$13.1M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$12.6M |
| 5 |
Cullen/Frost Bankers
CFR
|
+$12.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$18.1M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$4.79M |
| 3 |
US Bancorp
USB
|
+$4.28M |
| 4 |
Comcast
CMCSA
|
+$4.22M |
| 5 |
T. Rowe Price
TROW
|
+$4.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 12.66% |
| 3 | Financials | 11.11% |
| 4 | Industrials | 9.32% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Sun Communities
SUI
$15.3B
| $60.6K | ﹤0.01% |
461
| – | – |
|
627
Knife River
KNF
$4.48B
| $59.8K | ﹤0.01% |
+1,375
| New | +$58.3K |
|
628
British American Tobacco
BTI
$134B
| $59.8K | ﹤0.01% |
1,800
+1,791
| +19,900% | +$61.2K |
|
629
Avista
AVA
$3.46B
| $58.9K | ﹤0.01% |
1,500
| – | – |
|
630
Box
BOX
$4.36B
| $58.8K | ﹤0.01% |
2,000
| – | – |
|
631
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
| $58.7K | ﹤0.01% |
5,356
+3,900
| +268% | +$42.7K |
|
632
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $58.7K | ﹤0.01% |
+2,500
| New | +$59.2K |
|
633
Cleveland-Cliffs
CLF
$6.84B
| $58.7K | ﹤0.01% |
+3,500
| New | +$55.5K |
|
634
Revvity
RVTY
$12.4B
| $58.6K | ﹤0.01% |
493
| – | – |
|
635
Ennis
EBF
$554M
| $58.5K | ﹤0.01% |
2,871
| – | – |
|
636
Brookfield Asset Management
BAM
$76.7B
| $58K | ﹤0.01% |
1,777
| – | – |
|
637
Monster Beverage
MNST
$95.6B
| $57.4K | ﹤0.01% |
1,000
| – | – |
|
638
Chewy
CHWY
$9.38B
| $57.3K | ﹤0.01% |
1,451
+1,301
| +867% | +$45.3K |
|
639
AstraZeneca
AZN
$267B
| $56.7K | ﹤0.01% |
396
+84
| +27% | +$12.4K |
|
640
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.44B
| $56.4K | ﹤0.01% |
+2,402
| New | +$56.7K |
|
|
TSI
641
TCW Strategic Income Fund
TSI
$214M
| $56.3K | ﹤0.01% |
12,000
+5,000
| +71% | +$23.4K |
|
642
GSK
GSK
$108B
| $56K | ﹤0.01% |
1,559
| – | – |
|
643
Credit Acceptance
CACC
$5.84B
| $55.9K | ﹤0.01% |
110
| – | – |
|
644
Churchill Downs
CHDN
$6.22B
| $55.7K | ﹤0.01% |
+400
| New | +$54.7K |
|
645
Invesco S&P 500 Quality ETF
SPHQ
$19.3B
| $55.6K | ﹤0.01% |
+1,102
| New | +$53.1K |
|
646
Constellation Energy
CEG
$92.8B
| $55.6K | ﹤0.01% |
607
| – | – |
|
647
Valvoline
VVV
$5.13B
| $55.5K | ﹤0.01% |
+1,479
| New | +$53.7K |
|
|
WRK
648
DELISTED
WestRock Company
WRK
| $54.9K | ﹤0.01% |
1,890
| – | – |
|
649
Vanguard S&P 500 Growth ETF
VOOG
$25.2B
| $54.5K | ﹤0.01% |
1,284
| – | – |
|
650
Telephone and Data Systems
TDS
$3.87B
| $52.3K | ﹤0.01% |
6,354
-521
| -8% | -$4.42K |
|
Similar funds
SI
EGM
MT
CMTU
FMI
MAM
VIM
FIA
Bartlett & Co Wealth Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bartlett & Co Wealth Management held 1,221 positions worth $5.78B, up 12% from $5.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Bartlett & Co Wealth Management deployed $315M of net new capital in Q2 2023, opening 145 new positions and adding to 296 existing holdings. Its largest new stake was Toro Company: 25,480 shares worth $2.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.1M trimmed.
- Bartlett & Co Wealth Management's largest Q2 2023 buy was Toro Company: 25,480 shares worth $2.6M.
- Bartlett & Co Wealth Management added most to Chevron in Q2 2023, an estimated $21.8M increase.
- Bartlett & Co Wealth Management's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $18.1M.
- Bartlett & Co Wealth Management fully exited iPath Pure Beta Broad Commodity ETN in Q2 2023, selling an estimated $684K.
- Bartlett & Co Wealth Management's ten largest holdings make up 31% of its $5.78B portfolio in Q2 2023.
- Bartlett & Co Wealth Management opened 145 new positions and closed 48 in Q2 2023.
- Bartlett & Co Wealth Management's portfolio value rose 12% quarter-over-quarter to $5.78B.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2023, filed 14 Feb 2024.